Skip to main content

Table 3 Vaccination rate following HBV screening by sex and age group

From: World hepatitis day in Burkina Faso, 2017: seroprevalence and vaccination against hepatitis B virus to achieve the 2030 elimination goal

Variables Vaccinateda/Total % 1st dose 2nd dose 3rd dose Mean age
Sex
 Female 668/1139 58.6 675 672 668 29.8 ± 13.8
 Male 534/847 63.0 545 535 534 30.1 ± 14.1
 Total 1202/1986 60.5 1220 1207 1202 24.6 ± 4.7
Age
  ≤ 20 210/474 44.3 215 211 210 12.8 ± 5.4
 21–30 436/664 65.7 441 437 436 26.1 ± 2.8
 31–40 316/459 68.8 318 317 316 35.0 ± 2.8
 41–50 119/192 62.0 122 120 119 45.0 ± 2.8
 > 50 121/197 61.4 124 122 121 57.5 ± 6.0
Number of vaccinated individuals
 Female 668/1202 55.6 675 672 668 29.5 ± 12.7
 Male 534/1202 44.4 545 535 534 30.1 ± 11.2
Vaccination rate
 Female 668/1986 33.6 675 672 668 29.8 ± 13.8
 Male 534/1986 26.9 545 535 534 29.9 ± 13.9
  1. aAll vaccinated HBsAg individuals completed their three doses of hepatitis B vaccine